These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15189032

  • 1. Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs.
    Johansson PO, Chen Y, Belfrage AK, Blackman MJ, Kvarnström I, Jansson K, Vrang L, Hamelink E, Hallberg A, Rosenquist A, Samuelsson B.
    J Med Chem; 2004 Jun 17; 47(13):3353-66. PubMed ID: 15189032
    [Abstract] [Full Text] [Related]

  • 2. Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.
    Gupta D, Yedidi RS, Varghese S, Kovari LC, Woster PM.
    J Med Chem; 2010 May 27; 53(10):4234-47. PubMed ID: 20438064
    [Abstract] [Full Text] [Related]

  • 3. High antiplasmodial activity of novel plasmepsins I and II inhibitors.
    Dell'Agli M, Parapini S, Galli G, Vaiana N, Taramelli D, Sparatore A, Liu P, Dunn BM, Bosisio E, Romeo S.
    J Med Chem; 2006 Dec 14; 49(25):7440-9. PubMed ID: 17149873
    [Abstract] [Full Text] [Related]

  • 4. Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity.
    Ersmark K, Feierberg I, Bjelic S, Hamelink E, Hackett F, Blackman MJ, Hultén J, Samuelsson B, Aqvist J, Hallberg A.
    J Med Chem; 2004 Jan 01; 47(1):110-22. PubMed ID: 14695825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II.
    Dahlgren A, Kvarnström I, Vrang L, Hamelink E, Hallberg A, Rosenquist A, Samuelsson B.
    Bioorg Med Chem; 2003 Mar 20; 11(6):827-41. PubMed ID: 12614868
    [Abstract] [Full Text] [Related]

  • 7. Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D.
    Dali B, Keita M, Megnassan E, Frecer V, Miertus S.
    Chem Biol Drug Des; 2012 Apr 20; 79(4):411-30. PubMed ID: 22129033
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.
    Nöteberg D, Hamelink E, Hultén J, Wahlgren M, Vrang L, Samuelsson B, Hallberg A.
    J Med Chem; 2003 Feb 27; 46(5):734-46. PubMed ID: 12593654
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New potent C2-symmetric malaria plasmepsin I and II inhibitors.
    Oscarsson K, Oscarson S, Vrang L, Hamelink E, Hallberg A, Samuelsson B.
    Bioorg Med Chem; 2003 Apr 03; 11(7):1235-46. PubMed ID: 12628651
    [Abstract] [Full Text] [Related]

  • 15. New inhibitors of the malaria aspartyl proteases plasmepsin I and II.
    Dahlgren A, Kvarnström I, Vrang L, Hamelink E, Hallberg A, Rosenquist A, Samuelsson B.
    Bioorg Med Chem; 2003 Aug 05; 11(16):3423-37. PubMed ID: 12878137
    [Abstract] [Full Text] [Related]

  • 16. Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV.
    Ersmark K, Nervall M, Gutiérrez-de-Terán H, Hamelink E, Janka LK, Clemente JC, Dunn BM, Gogoll A, Samuelsson B, Qvist J, Hallberg A.
    Bioorg Med Chem; 2006 Apr 01; 14(7):2197-208. PubMed ID: 16307884
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II.
    Haque TS, Skillman AG, Lee CE, Habashita H, Gluzman IY, Ewing TJ, Goldberg DE, Kuntz ID, Ellman JA.
    J Med Chem; 1999 Apr 22; 42(8):1428-40. PubMed ID: 10212129
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.